1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Global Veterinary Molecular Diagnostics Market Forecast
4.5. Global Veterinary Molecular Diagnostics Market Outlook
5. Market Outlook
5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)
5.2. Pet Ownership Statistics
5.3. List of Pathogens for responsible for Canine, Feline, and Equine Diseases
5.4. Covid-19 Impact Analysis
5.5. Pros and Cons of Each Type of PCR Test
5.6. Technological Advancement
5.7. Most commonly Used Instruments for Veterinary Diagnostics
5.8. Veterinary Medical Device Regulation
6. Global Veterinary Molecular Diagnostics Market Analysis, by Product Type
6.1. Introduction
6.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
6.3. Global Veterinary Molecular Diagnostics Market Forecast, by Product Type
6.3.1. Instruments & Software
6.3.2. Kits & Reagents
6.3.3. Services
6.4. Global Veterinary Molecular Diagnostics Market Analysis, by Product Type
7. Global Veterinary Molecular Diagnostics Market Analysis, by Technology
7.1. Introduction
7.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
7.3. Global Veterinary Molecular Diagnostics Market Forecast, by Technology
7.3.1. Conventional PCR
7.3.2. Singleplex PCR
7.3.3. Multiplex PCR
7.3.4. Real-time PCR
7.3.5. Others
7.4. Global Veterinary Molecular Diagnostics Market Analysis, by Technology
8. Global Veterinary Molecular Diagnostics Market Analysis, by Disease Type
8.1. Introduction
8.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
8.3. Global Veterinary Molecular Diagnostics Market Forecast, by Disease Type
8.3.1. Vector-borne Diseases
8.3.2. Respiratory Pathogens
8.3.3. Diarrhea Pathogens
8.3.4. Others
8.4. Global Veterinary Molecular Diagnostics Market Analysis, by Disease Type
9. Global Veterinary Molecular Diagnostics Market Analysis, by Animal Type
9.1. Introduction
9.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
9.3. Global Veterinary Molecular Diagnostics Market Forecast, by Animal Type
9.3.1. Companion Animals
9.3.1.1. Canine
9.3.1.2. Feline
9.3.1.3. Others
9.3.2. Livestock Animals
9.4. Global Veterinary Molecular Diagnostics Market Analysis, by Animal Type
10. Global Veterinary Molecular Diagnostics Market Analysis, by End-user
10.1. Introduction
10.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
10.3. Global Veterinary Molecular Diagnostics Market Forecast, by End-user
10.3.1. Hospitals/Clinics
10.3.2. Reference Laboratories
10.4. Global Veterinary Molecular Diagnostics Market Analysis, by End-user
11. Global Veterinary Molecular Diagnostics Market Analysis, by Region
11.1. Global Veterinary Molecular Diagnostics Market Scenario, by Region/Country
11.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Region
11.3. Global Veterinary Molecular Diagnostics Market Forecast, by Region
11.3.1. North America
11.3.2. Europe
11.3.3. Asia Pacific
11.3.4. Latin America
11.3.5. Middle East & Africa
12. North America Veterinary Molecular Diagnostics Market Analysis
12.1. North America Veterinary Molecular Diagnostics Market Overview
12.2. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country
12.3. North America Veterinary Molecular Diagnostics Market Forecast, by Country
12.3.1. U.S.
12.3.2. Canada
12.4. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
12.5. North America Veterinary Molecular Diagnostics Market Forecast, by Product Type
12.5.1. Instruments & Software
12.5.2. Kits & Reagents
12.5.3. Services
12.6. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
12.7. North America Veterinary Molecular Diagnostics Market Forecast, by Technology
12.7.1. Conventional PCR
12.7.2. Singleplex PCR
12.7.3. Multiplex PCR
12.7.4. Real-time PCR
12.7.5. Others
12.8. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
12.9. North America Veterinary Molecular Diagnostics Market Forecast, by Disease Type
12.9.1. Vector-borne Diseases
12.9.2. Respiratory Pathogens
12.9.3. Diarrhea Pathogens
12.9.4. Others
12.10. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
12.11. North America Veterinary Molecular Diagnostics Market Forecast, by Animal Type
12.11.1. Companion Animals
12.11.1.1. Canine
12.11.1.2. Feline
12.11.1.3. Others
12.11.2. Livestock Animals
12.12. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
12.13. North America Veterinary Molecular Diagnostics Market Forecast, by End-user
12.13.1. Hospitals/Clinics
12.13.2. Reference Laboratories
13. Europe Veterinary Molecular Diagnostics Market Analysis
13.1. Europe Veterinary Molecular Diagnostics Market Overview
13.2. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Europe Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region
13.3.1. Germany
13.3.2. U.K.
13.3.3. France
13.3.4. Italy
13.3.5. Spain
13.3.6. Rest of Europe
13.4. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
13.5. Europe Veterinary Molecular Diagnostics Market Forecast, by Product Type
13.5.1. Instruments & Software
13.5.2. Kits & Reagents
13.5.3. Services
13.6. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
13.7. Europe Veterinary Molecular Diagnostics Market Forecast, by Technology
13.7.1. Conventional PCR
13.7.2. Singleplex PCR
13.7.3. Multiplex PCR
13.7.4. Real-time PCR
13.7.5. Others
13.8. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
13.9. Europe Veterinary Molecular Diagnostics Market Forecast, by Disease Type
13.9.1. Vector-borne Diseases
13.9.2. Respiratory Pathogens
13.9.3. Diarrhea Pathogens
13.9.4. Others
13.10. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
13.11. Europe Veterinary Molecular Diagnostics Market Forecast, by Animal Type
13.11.1. Companion Animals
13.11.1.1. Canine
13.11.1.2. Feline
13.11.1.3. Others
13.11.2. Livestock Animals
13.12. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
13.13. Europe Veterinary Molecular Diagnostics Market Forecast, by End-user
13.13.1. Hospitals/Clinics
13.13.2. Reference Laboratories
14. Asia Pacific Veterinary Molecular Diagnostics Market Analysis
14.1. Asia Pacific Veterinary Molecular Diagnostics Market Overview
14.2. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region
14.3.1. China
14.3.2. Japan
14.3.3. India
14.3.4. Australia & New Zealand
14.3.5. Rest of Asia Pacific
14.4. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
14.5. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Product Type
14.5.1. Instruments & Software
14.5.2. Kits & Reagents
14.5.3. Services
14.6. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
14.7. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Technology
14.7.1. Conventional PCR
14.7.2. Singleplex PCR
14.7.3. Multiplex PCR
14.7.4. Real-time PCR
14.7.5. Others
14.8. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
14.9. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Disease Type
14.9.1. Vector-borne Diseases
14.9.2. Respiratory Pathogens
14.9.3. Diarrhea Pathogens
14.9.4. Others
14.10. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
14.11. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Animal Type
14.11.1. Companion Animals
14.11.1.1. Canine
14.11.1.2. Feline
14.11.1.3. Others
14.11.2. Livestock Animals
14.12. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
14.13. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by End-user
14.13.1. Hospitals/Clinics
14.13.2. Reference Laboratories
15. Latin America Veterinary Molecular Diagnostics Market Analysis
15.1. Latin America Veterinary Molecular Diagnostics Market Overview
15.2. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
15.3. Latin America Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region
15.3.1. Brazil
15.3.2. Mexico
15.3.3. Rest of Latin America
15.4. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
15.5. Latin America Veterinary Molecular Diagnostics Market Forecast, by Product Type
15.5.1. Instruments & Software
15.5.2. Kits & Reagents
15.5.3. Services
15.6. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
15.7. Latin America Veterinary Molecular Diagnostics Market Forecast, by Technology
15.7.1. Conventional PCR
15.7.2. Singleplex PCR
15.7.3. Multiplex PCR
15.7.4. Real-time PCR
15.7.5. Others
15.8. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
15.9. Latin America Veterinary Molecular Diagnostics Market Forecast, by Disease Type
15.9.1. Vector-borne Diseases
15.9.2. Respiratory Pathogens
15.9.3. Diarrhea Pathogens
15.9.4. Others
15.10. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
15.11. Latin America Veterinary Molecular Diagnostics Market Forecast, by Animal Type
15.11.1. Companion Animals
15.11.1.1. Canine
15.11.1.2. Feline
15.11.1.3. Others
15.11.2. Livestock Animals
15.12. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
15.13. Latin America Veterinary Molecular Diagnostics Market Forecast, by End-user
15.13.1. Hospitals/Clinics
15.13.2. Reference Laboratories
16. Middle East & Africa Veterinary Molecular Diagnostics Market Analysis
16.1. Middle East & Africa Veterinary Molecular Diagnostics Market Overview
16.2. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
16.3. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region
16.3.1. GCC Countries
16.3.2. South Africa
16.3.3. Rest of Middle East & Africa
16.4. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
16.5. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Product Type
16.5.1. Instruments & Software
16.5.2. Kits & Reagents
16.5.3. Services
16.6. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
16.7. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Technology
16.7.1. Conventional PCR
16.7.2. Singleplex PCR
16.7.3. Multiplex PCR
16.7.4. Real-time PCR
16.7.5. Others
16.8. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
16.9. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Disease Type
16.9.1. Vector-borne Diseases
16.9.2. Respiratory Pathogens
16.9.3. Diarrhea Pathogens
16.9.4. Others
16.10. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
16.11. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Animal Type
16.11.1. Companion Animals
16.11.1.1. Canine
16.11.1.2. Feline
16.11.1.3. Others
16.11.2. Livestock Animals
16.12. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
16.13. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by End-user
16.13.1. Hospitals/Clinics
16.13.2. Reference Laboratories
17. Competition Landscape
17.1. Competition Matrix
17.2. Global Veterinary Molecular Diagnostics Market Share Analysis, by Company
17.3. Company Profiles
17.3.1. IDEXX Laboratories, Inc.
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Financial Overview
17.3.1.3. Product Portfolio
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. Thermo Fisher Scientific, Inc.
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Financial Overview
17.3.2.3. Product Portfolio
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. Zoetis, Inc.
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Financial Overview
17.3.3.3. Product Portfolio
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Neogen Corporation
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. SWOT Analysis
17.3.4.4. Strategic Overview
17.3.5. bioMérieux SA
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Financial Overview
17.3.5.3. Product Portfolio
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. QIAGEN N.V.
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Financial Overview
17.3.6.3. Product Portfolio
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Biomedica Medizinprodukte GmbH & Co KG
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. SWOT Analysis
17.3.7.4. Strategic Overview
17.3.8. Bioneer
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. SWOT Analysis
17.3.8.4. Strategic Overview
17.3.9. VCA, Inc. (subsidiary of Mars, Incorporated)
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. SWOT Analysis
17.3.9.4. Strategic Overview
17.3.10. ID.VET
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Product Portfolio
17.3.10.3. SWOT Analysis
17.3.10.4. Strategic Overview